TRIANA Biomedicines
MA - LexingtonBiotechnology
Focus: TRIANA Biomedicines is a public biotechnology company headquartered in Lexington, MA, specializing in a proprietary platform for discovering and developing molecular glues targeting E3 ubiquitin ligases. The company operates at an early clinical stage with a focused pipeline in oncology.
Profile data last refreshed 9h ago · AI intelligence enriched 9h ago
Funding Stage
PUBLIC
Open Jobs
0
About TRIANA Biomedicines
AI assessmentNot HiringNo open roles listed right now. Follow TRIANA Biomedicines to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TRI-611
ALK-positive NSCLCClinical Trials (1)
NCT07491497A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
Phase 1/2Help build intelligence for TRIANA Biomedicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.